These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31820472)

  • 1. Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids.
    Zhou X; Wang S; Zhu Y; Pan Y; Zhang L; Yang Z
    Med Res Rev; 2020 Jul; 40(4):1178-1199. PubMed ID: 31820472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices.
    Allain V; Bourgaux C; Couvreur P
    Nucleic Acids Res; 2012 Mar; 40(5):1891-903. PubMed ID: 22075995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolipids: natural occurrence, synthesis, molecular recognition, and supramolecular assemblies as potential precursors of life and bioorganic materials.
    Rosemeyer H
    Chem Biodivers; 2005 Aug; 2(8):977-1063. PubMed ID: 17193189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer.
    Peters GJ; Adema AD; Bijnsdorp IV; Sandvold ML
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1168-80. PubMed ID: 22132972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of nucleolipids as possible activated precursors for oligomer formation via intramolecular catalysis: stability study and supramolecular organization.
    Gangadhara KL; Srivastava P; Rozenski J; Mattelaer HP; Leen V; Dehaen W; Hofkens J; Lescrinier E; Herdewijn P
    J Syst Chem; 2014; 5():5. PubMed ID: 25558290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside, nucleotide and oligonucleotide based amphiphiles: a successful marriage of nucleic acids with lipids.
    Gissot A; Camplo M; Grinstaff MW; Barthélémy P
    Org Biomol Chem; 2008 Apr; 6(8):1324-33. PubMed ID: 18385837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to increase the oral bioavailability of nucleoside analogs.
    Lalanne M; Andrieux K; Couvreur P
    Curr Med Chem; 2009; 16(11):1391-9. PubMed ID: 19355894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical details on nucleolipid supramolecular architecture: molecular modeling and physicochemical studies.
    Taib N; Aimé A; Houmadi S; Castano S; Barthélémy P; Laguerre M; Bestel I
    Langmuir; 2012 May; 28(19):7452-60. PubMed ID: 22482866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Cleavable Nucleoside Lipids: A New Paradigm for Controlling the Stability of Lipid-Based Delivery Systems.
    Oumzil K; Benizri S; Tonelli G; Staedel C; Appavoo A; Chaffanet M; Navailles L; Barthélémy P
    ChemMedChem; 2015 Nov; 10(11):1797-801. PubMed ID: 26381578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress on the nucleoside/nucleotide-loaded nanomedicines.
    Zhou Z; Liu H; Ye M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):279-284. PubMed ID: 37476939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolipids as potential organogelators.
    Rosemeyer H; Stürenberg EM; Herdewijn P
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):995-9. PubMed ID: 18058524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of hydrophilic guest molecules from photoresponsive nucleolipid vesicles.
    Sun Y; Yan Y; Wang M; Chen C; Xu H; Lu JR
    ACS Appl Mater Interfaces; 2013 Jul; 5(13):6232-6. PubMed ID: 23758265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent patents in cationic lipid carriers for delivery of nucleic acids.
    Koynova R; Tenchov B
    Recent Pat DNA Gene Seq; 2011 Apr; 5(1):8-27. PubMed ID: 21288191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).
    Hope MJ; Mui B; Ansell S; Ahkong QF
    Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular recognition of nucleic acids by nucleolipid/dendrimer surface complexes.
    Arteta MY; Berti D; Montis C; Campbell RA; Clifton LA; Skoda MW; Soltwedel O; Baglioni P; Nylander T
    Soft Matter; 2014 Nov; 10(42):8401-5. PubMed ID: 25246334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside-lipid-based nanoparticles for cisplatin delivery.
    Khiati S; Luvino D; Oumzil K; Chauffert B; Camplo M; Barthélémy P
    ACS Nano; 2011 Nov; 5(11):8649-55. PubMed ID: 21961944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Therapeutic
    Dantsu Y; Zhang Y; Zhang W
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient delivery of therapeutic small nucleic acids to prostate cancer cells using ketal nucleoside lipid nanoparticles.
    Luvino D; Khiati S; Oumzil K; Rocchi P; Camplo M; Barthélémy P
    J Control Release; 2013 Dec; 172(3):954-61. PubMed ID: 24041711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.